Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Tea polyphenols, particularly those found in green tea such as epigallocatechin gallate (EGCG), have been studied for their potential effects on blood clot formation (thrombosis). Laboratory and animal studies suggest that tea polyphenols may have antithrombotic properties, primarily by inhibiting platelet aggregation, modulating endothelial function, and exerting antioxidant effects that reduce vascular inflammation. Some in vitro studies have demonstrated that EGCG can suppress platelet activation and aggregation, both of which are critical steps in clot formation. Epidemiological studies associate regular tea consumption with a lower risk of cardiovascular events, which may include thrombotic events, though these studies typically do not isolate tea polyphenols as the sole active component. However, direct clinical evidence in humans specifically addressing the prevention or treatment of blood clots with tea polyphenols is limited. Most human studies focus on surrogate markers such as platelet aggregation or vascular function rather than actual incidence of thrombosis. No major clinical guidelines recommend tea polyphenols for the prevention or treatment of blood clots, and the evidence remains preliminary. Therefore, while there is some scientific basis and biological plausibility for tea polyphenols supporting blood clot prevention, the strength of evidence is moderate to low (rated 2 out of 5) and largely based on preclinical or observational data rather than robust clinical trials.

More about Tea Polyphenol
More about Blood Clots (prevention of)

Other ingredients used for Blood Clots (prevention of)

Other health conditions supported by Tea Polyphenol

Products containing Tea Polyphenol